Protagenic Therapeutics Net Asset Quality Index
Protagenic Therapeutics net asset quality index. Protagenic Therapeutics (PTIX) has a Net Asset Quality Index of -220.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.13 Million minus total liabilities of $6.82 Million yields net assets of $-4.69 Million. A higher index indicates a stronger, lower-leverage balance sheet. See PTIX net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Protagenic Therapeutics (1995–2025)
Net asset quality index of Protagenic Therapeutics from 1995 to 2025. This chart shows how Protagenic Therapeutics's Net Asset Quality Index has evolved across 30 annual periods from 1995 to 2025. As of December 2025, the index stands at -220.1%, representing net assets of $-4.69 Million against total assets of $2.13 Million USD. Check PTIX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Protagenic Therapeutics Net Asset Quality Index by Year (1995–2025)
Protagenic Therapeutics net asset quality index by year from 1995 to 2025. The table below presents the year-by-year Net Asset Quality Index for Protagenic Therapeutics from 1995 to 2025, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PTIX market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -220.1% | $-4.69 Million | $2.13 Million | $6.82 Million | ▼ -271.9 pp |
| 2024 | 51.8% | $1.01 Million | $1.96 Million | $942.76K | ▼ -33.0 pp |
| 2023 | 84.8% | $3.67 Million | $4.32 Million | $655.25K | ▼ -1.2 pp |
| 2022 | 86.1% | $6.92 Million | $8.04 Million | $1.12 Million | ▼ -3.8 pp |
| 2021 | 89.9% | $9.94 Million | $11.06 Million | $1.12 Million | ▲ +220.7 pp |
| 2020 | -130.8% | $-1.15 Million | $879.25K | $2.03 Million | ▼ -55.4 pp |
| 2019 | -75.3% | $-634.37K | $842.27K | $1.48 Million | ▼ -45.1 pp |
| 2018 | -30.3% | $-210.88K | $696.88K | $907.77K | ▼ -98.7 pp |
| 2017 | 68.5% | $1.22 Million | $1.78 Million | $561.69K | ▼ -9.9 pp |
| 2016 | 78.3% | $2.48 Million | $3.16 Million | $684.86K | ▲ +507.7 pp |
| 2015 | -429.3% | $-571.00K | $133.00K | $704.00K | ▼ -55.6 pp |
| 2015 | -373.7% | $-497.00K | $133.00K | $630.00K | ▼ -345.2 pp |
| 2014 | -28.5% | $-70.00K | $246.00K | $316.00K | ▲ +0.0 pp |
| 2013 | -28.5% | $-70.00K | $246.00K | $316.00K | ▲ +1777.2 pp |
| 2012 | -1805.7% | $-17.23 Million | $954.00K | $18.18 Million | ▼ -1847.9 pp |
| 2010 | 42.3% | $8.17 Million | $19.34 Million | $11.17 Million | ▼ -14.6 pp |
| 2009 | 56.8% | $25.35 Million | $44.60 Million | $19.25 Million | ▼ -12.5 pp |
| 2008 | 69.4% | $54.65 Million | $78.76 Million | $24.11 Million | ▼ -1.0 pp |
| 2007 | 70.4% | $16.86 Million | $23.96 Million | $7.10 Million | ▲ +48.1 pp |
| 2006 | 22.3% | $1.22 Million | $5.49 Million | $4.27 Million | ▼ -17.1 pp |
| 2004 | 39.4% | $2.74 Million | $6.95 Million | $4.21 Million | ▲ +3.1 pp |
| 2003 | 36.2% | $4.98 Million | $13.74 Million | $8.76 Million | ▼ -23.6 pp |
| 2002 | 59.8% | $12.87 Million | $21.53 Million | $8.65 Million | ▲ +1.5 pp |
| 2001 | 58.3% | $13.57 Million | $23.27 Million | $9.71 Million | ▼ -2.2 pp |
| 2000 | 60.5% | $13.86 Million | $22.92 Million | $9.06 Million | ▲ +2.6 pp |
| 1999 | 57.9% | $13.27 Million | $22.93 Million | $9.66 Million | ▼ -7.1 pp |
| 1998 | 64.9% | $13.95 Million | $21.48 Million | $7.53 Million | ▼ -19.4 pp |
| 1997 | 84.3% | $13.30 Million | $15.77 Million | $2.47 Million | ▲ +28.3 pp |
| 1996 | 56.0% | $7.04 Million | $12.57 Million | $5.53 Million | ▼ -11.8 pp |
| 1995 | 67.8% | $7.51 Million | $11.08 Million | $3.57 Million | — |